Immunoregulation of asthma by type2 cytokine therapies - treatments for all ages?
Sign Up to like & getrecommendations! Published in 2023 at "European journal of immunology"
DOI: 10.1002/eji.202249919
Abstract: Asthma is classically considered to be a disease of type 2 immune dysfunction, since many patients exhibit the consequences of excess secretion of cytokines such as IL-4, IL-5 and IL-13 concomitant with inflammation typified by… read more here.
Keywords: immunoregulation asthma; type2 cytokine; cytokine therapies; therapies treatments ... See more keywords